We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 18

Asia’s biomedical R&D spend rises, while U.S. investment declines
  • Shook Hardy & Bacon LLP
  • China, USA
  • January 9 2014

Researchers have found that the U.S. global share of biomedical research expenditures fell from 51 percent in 2007 to 45 percent in 2012, while China


China to establish food and safety ‘blacklist’
  • Shook Hardy & Bacon LLP
  • China, USA
  • December 20 2013

The Chinese Food and Drug Administration (CFDA) has announced a public consultation on a draft regulation, "Provisions on the Administration of the


China’s medical device regulations take effect June 1
  • Shook Hardy & Bacon LLP
  • China
  • May 1 2014

According to news sources, China's amended medical device rules, which increase fines for illegal manufacturing and strengthen government oversight


Large-scale joint drug venture and MOUs bind North Carolina and China’s Zhejian
  • Shook Hardy & Bacon LLP
  • China, USA
  • August 4 2011

North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province


China cracks down on food producers in major food safety campaign
  • Shook Hardy & Bacon LLP
  • China
  • August 5 2011

According to a news source, Chinese officials have arrested about 2,000 people and shut down almost 5,000 food production facilities since April 2011, in an effort to stop the industry’s use of illegal food additives


Cuba, China agree to strengthen biotechnology collaboration
  • Shook Hardy & Bacon LLP
  • China, Cuba
  • December 15 2011

Cuba and China have reportedly signed agreements to deepen their collaboration on biotechnology


WHO issues global alert on new strain of avian influenza (H7N9)
  • Shook Hardy & Bacon LLP
  • China, Global, USA
  • April 12 2013

The World Health Organization (WHO) has issued a global alert and response update on a new strain of novel avian influenza A (H7N9) virus identified


Researchers identify antibiotic-resistant bacteria in pig manure
  • Shook Hardy & Bacon LLP
  • China, USA
  • February 15 2013

A new study has reportedly confirmed the presence of antibiotic-resistant genes (ARGs) in manure samples harvested from swine farms in China, raising


Chinese billionaire backs U.S.China biopharma venture
  • Shook Hardy & Bacon LLP
  • China, USA
  • April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks


Medicinova and Zhejiang Medicine announce joint venture in China
  • Shook Hardy & Bacon LLP
  • China, USA
  • March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China